Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  amifostine trihydrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 128 for your search:
Start Over
Phase IV Study of Amifostine for Chemotherapy Induced Peripheral Neuropathy in Patients with Cancer (Summary Last Modified 04/2000)
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: RNSMC-AM9702, ALZA-RNSMC-AM9702, NCI-V98-1390, NCT00003252
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Phase: Phase IV
Type: Supportive care
Status: Temporarily closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: SUN-2011-DP, NCT01288625
Phase II/III Randomized Study of Amifostine Followed By Protracted Fractionated Radiotherapy in Patients With Inoperable, Unresectable, or Postoperatively Recurrent Rectal Adenocarcinoma (Summary Last Modified 11/2001)
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to physiologic 74
Sponsor: NCI
Protocol IDs: UPCC-00-A-0465, NCI-T87-0232
Phase I Pilot/Phase III Randomized Study of CDDP and Combined External-Beam/Intracavitary Radiotherapy with vs without WR-2721 in Patients with Stages IIA-IVA and Selected Stage IB Carcinoma of the Uterine Cervix
Phase: Phase III, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: AECM-8908198, NCI-V92-0084
Phase III Randomized Study of Radiotherapy with vs without Amifostine for Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 04/98)
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: USB-WR-38, NCI-V96-1083
Phase III Randomized Study of Amifostine in Reducing Cisplatin Induced Ototoxicity in Cancer Patients
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UCMC-971163, ALZA-UCMC-971163, NCI-V97-1330
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9801, CDR0000066260, NCT00003313
Phase III Randomized Study of Pentoxifylline, Ciprofloxacin, and Dexamethasone Versus Amifostine in Patients with Myelodysplastic Syndromes (Summary Last Modified 08/1998)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BOSTON-VAMC-523, ALZA-97-047-ii, NCI-V98-1422
Phase III Randomized Comparison of CACP vs CACP plus WR-2721 in Patients with Disseminated Malignant Melanoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1686
Phase III Study of High-Dose CTX plus GM-CSF with vs without WR-2721 Chemoprotection in Patients with Advanced Malignancies
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CLB-9160, CALGB-9160
Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000285700, GOG-0192, NCT00058071
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 2004.00, NCI-2009-01543, FHCRC-2004.00, 6004, MEDIMMUNE-FHCRC-2004.00, NCT00217438
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: ARAR0331, NCI-2009-00412, COG-ARAR0331, CDR0000454849, U10CA098543, NCT00274937
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 97CC4, NCI-G99-1633, NCT00004166
Phase I/II Study of Amifostine in Patients with Myelodysplasia
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-97076, ALZA-97-013-ii, NCI-G97-1338
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: 8433, UCCRC-8433, ALZA-97-005-ii, NCI-V97-1357, NCT00003136
Phase I/II Study of Amifostine in Ameliorating Chronic Toxicity of Fludarabine Monophosphate
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: UARIZ-HSC-97116, ALZA-UARIZ-HSC-97116, NCI-V98-1371
Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000066028, MGH-M7-20, ALZA-97-024-ii, NCI-V98-1384, NCT00003193
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066087, P30CA016042, UCLA-HSPC-970304601B, ALZA-UCLA-HSPC-970304601B, NCI-G98-1390, NCT00003225
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 14 to 70
Sponsor: Other
Protocol IDs: UKMC-97BMT72, CDR0000066448, ALZA-UKMC-97BMT72, NCI-V98-1455, NCT00003425
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UMIAMI-88191, SCCC-1988007, ALZA-97-052-ii, BHM-98-32, NCI-V98-1474, SCCC-97098, NCT00003582
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068021, NCCTG-N9923, N9923, NCT00006012
Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0116, CDR0000068472, RTOG-C-0116, NCT00012012
Start Over